KLEANTHIS G XANTHOPOULOS Insider Trading $ZSAN Zosano Pharma Corp
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KLEANTHIS G XANTHOPOULOS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KLEANTHIS G XANTHOPOULOS. KLEANTHIS G XANTHOPOULOS is Director in APRICUS BIOSCIENCES, INC. ($APRI) and President and CEO in Regulus Therapeutics Inc. ($RGLS) and in Zosano Pharma Corp ($ZSAN) and Director in Zosano Pharma Corp ($ZSAN).
KLEANTHIS G XANTHOPOULOS in Zosano Pharma Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KLEANTHIS G XANTHOPOULOS: Director
Holdings: 23,596 shares
Current Value: $28,315
Latest Transaction: Jun 14 2021
$ZSAN Market Capitalization: $19.67M
$ZSAN Previous Close: $1.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KLEANTHIS G XANTHOPOULOS in Zosano Pharma Corp
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, RGLS, SEEL, ZSAN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14 2021 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 0.93 | 30,000 | 27,954 | 30,000 | |
| Jun 14 2021 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Grant | A | 0.00 | 15,000 | 0 | 23,596 | 8.6 K to 23.6 K (+174.50 %) |
| Jun 29 2020 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Grant | A | 0.00 | 7,500 | 0 | 8,596 | 1.1 K to 8.6 K (+684.31 %) | |
| Jun 05 2020 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 1.01 | 15,000 | 15,150 | 15,000 | |
| Jul 18 2019 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 2.34 | 1,500 | 3,510 | 1,500 | |
| Jun 01 2018 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 4.24 | 25,000 | 106,000 | 25,000 | |
| Mar 02 2018 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 0.53 | 30,000 | 15,900 | 30,000 | |
| Nov 04 2016 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 0.58 | 20,000 | 11,500 | 20,000 | |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | P | 1.55 | 15,920 | 24,676 | 15,920 | |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | P | 1.45 | 15,920 | 23,084 | 15,920 | |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Buy | P | 1.32 | 15,920 | 21,014 | 21,920 | 6 K to 21.9 K (+265.33 %) |
| Apr 02 2015 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
Page: 1